Current Funding
Check back later.
Completed Funding
Department of the Army, Medical Research, PR141776
“Discovery of Novel N-Nicotinamide Methyltransferase Inhibitors to Combat Obesity-Linked Osteoarthritis and Metabolic Disease among Veterans and Beneficiaries”. Collaboration with UTMB Galveston.
Cancer Prevention & Research Institute of Texas, DP150055
“Druggable Targets that Regulate the Antitumor Activity of ER-beta”. Collaboration with UT Health San Antonio.
IIMS/CTSA (NIH) pilot award
“Development of novel FAAH Inhibitors for the Treatment of Schizophrenia”. Collaboration with UT Health San Antonio
IIMS/CTSA (NIH) pilot award
“Discovery of novel inhibitors of oncoprotein EYA2 in breast and ovarian cancers”. Collaboration with UT Health San Antonio.
Cancer Prevention & Research Institute of Texas, RP160844
“Center for Innovative Drug Discovery: Enhancement of a Shared Cancer Resource for South Texas”. Collaboration with UT Health San Antonio.
Cancer Prevention & Research Institute of Texas, RP200058
“Enhancing Cytarabine Response Through SAMHD1 Inhibition”.
Department of Defense CDMRP, PR171296
“Protein Kinase C Epsilon Inhibitors to Treat Pain”. Collaboration with UT Austin and UC San Francisco
National Institutes of Health R01 AI119554
“Development of novel chemical series of Candida albicans biofilm inhibitors”. Collaboration with Jose Lopez Ribot (UTSA).
National Institutes of Health R01 AI115691
“Structure-guided redesign of an antischistosomal drug”. Collaboration with UT Health San Antonio and Texas BioMed.
San Antonio Partnership for Precision Therapeutics
“Blocking SARS-CoV-2 Evasion from Innate Antiviral Defenses”.
San Antonio Partnership for Precision Therapeutics
“Role of FURIN in COVID-19 and Underlying Molecular and Immunological Mechanisms”.
San Antonio Partnership for Precision Therapeutics
“Mechanism-Based Targeting of an RNA Processing Pathway”.
National Institutes of Health 5UL1TR002645
“Institution for the Integration of Medicine and Science: A Partnership to Improve Health”.
CTSA Optional Core Facility Grant